Inter‐ and intra‐patient heterogeneity of PD‐L1 expression in metastatic melanomas: A retrospective study
Sign Up to like & getrecommendations! Published in 2020 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13498
Abstract: Immunotherapy with PD-1/PD-L1 axis blockers by inhibiting the binding of PD-1 with its ligands has become an important strategy in advanced melanoma. There is an objective response in 50% of patients with melanoma metastases, and… read more here.
Keywords: melanoma; melanomas; study; metastatic melanomas ... See more keywords
Proteomic profiling of cutaneous melanoma explains the aggressiveness of distant organ metastasis.
Sign Up to like & getrecommendations! Published in 2023 at "Experimental dermatology"
DOI: 10.1111/exd.14814
Abstract: Despite recent developments in managing metastatic melanomas, patients' overall survival remains low. Therefore, the current study aims to understand better the proteome-wide changes associated with melanoma metastasis that will assist with identifying targeted therapies. The… read more here.
Keywords: metastasis; proteomic profiling; metastatic melanomas; organ metastatic ... See more keywords